All Stories

  1. Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer
  2. Lost expression of ADAMTS5 protein associates with progression and poor prognosis of hepatocellular carcinoma
  3. Upregulation of PD-L1 and APE1 is associated with tumorigenesis and poor prognosis of gastric cancer
  4. Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathway
  5. Identification of a novel potential antitumor activity of gossypol as an APE1/Ref-1 inhibitor
  6. Association of DNA base excision repair genes (OGG1 , APE1 and XRCC1 ) polymorphisms with outcome to platinum-based chemotherapy in advanced nonsmall-cell lung cancer patients
  7. Apurinic/apyrimidinic endonuclease 1 induced upregulation of fibroblast growth factor 2 and its receptor 3 induces angiogenesis in human osteosarcoma cells